Stromal contribution to the colorectal cancer transcriptome
- PMID: 25706627
- DOI: 10.1038/ng.3224
Stromal contribution to the colorectal cancer transcriptome
Erratum in
-
Corrigendum: Stromal contribution to the colorectal cancer transcriptome.Nat Genet. 2016 Sep 28;48(10):1296. doi: 10.1038/ng1016-1296d. Nat Genet. 2016. PMID: 27681291 No abstract available.
Abstract
Recent studies identified a poor-prognosis stem/serrated/mesenchymal (SSM) transcriptional subtype of colorectal cancer (CRC). We noted that genes upregulated in this subtype are also prominently expressed by stromal cells, suggesting that SSM transcripts could derive from stromal rather than epithelial cancer cells. To test this hypothesis, we analyzed CRC expression data from patient-derived xenografts, where mouse stroma supports human cancer cells. Species-specific expression analysis showed that the mRNA levels of SSM genes were mostly due to stromal expression. Transcriptional signatures built to specifically report the abundance of cancer-associated fibroblasts (CAFs), leukocytes or endothelial cells all had significantly higher expression in human CRC samples of the SSM subtype. High expression of the CAF signature was associated with poor prognosis in untreated CRC, and joint high expression of the stromal signatures predicted resistance to radiotherapy in rectal cancer. These data show that the distinctive transcriptional and clinical features of the SSM subtype can be ascribed to its particularly abundant stromal component.
Comment in
-
Tumour microenvironment: Driving relapse.Nat Rev Cancer. 2015 Apr;15(4):195. doi: 10.1038/nrc3935. Nat Rev Cancer. 2015. PMID: 25801612 No abstract available.
-
Colorectal cancer: Back to the stroma--the real villain in colorectal cancer?Nat Rev Gastroenterol Hepatol. 2015 May;12(5):256-8. doi: 10.1038/nrgastro.2015.57. Epub 2015 Apr 21. Nat Rev Gastroenterol Hepatol. 2015. PMID: 25895818 No abstract available.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions

